Chugai Pharmaceutical Co. Ltd. has entered into a license agreement with FRONTEO Inc. for a drug discovery support system based on artificial intelligence (AI). Under the license agreement, Amanogawa (trademark-pending), a literature search system with AI which employs Concept Encoder (conceptencoder), a unique AI system for natural language processing developed by FRONTEO, and Cascade Eye, a newly developed system which is capable of visualizing information on disease mechanism in the form of a pathway map, will be utilized in Chugai's drug discovery process.